Two decades of experience with hepatic cryotherapy for advanced colorectal metastases

Annals of Surgical Oncology

Volumn 19, Issue 4, 2012, Pages 1276-1283

  Ng, Keh M ^a   Chua, Terence C ^a   Saxena, Akshat ^a   Zhao, Jing ^a   Chu, Francis ^a   Morris, David L ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; ADVANCED CANCER; ARTICLE; CANCER ADJUVANT THERAPY; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; COLORECTAL METASTASIS; CRYOTHERAPY; DISEASE FREE SURVIVAL; FEMALE; HEPATIC CRYOTHERAPY; HUMAN; MAJOR CLINICAL STUDY; MALE; METASTASIS; OVERALL SURVIVAL; RETROSPECTIVE STUDY;

COLORECTAL NEOPLASMS; CRYOSURGERY; DISEASE-FREE SURVIVAL; FEMALE; HEPATECTOMY; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER NEOPLASMS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; PERITONEAL NEOPLASMS; PROGNOSIS; SURVIVAL RATE;

EID: 84862498647     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-011-2025-4     Document Type: Article

References (25)

1. Bengmark S, Hafstrom L. The natural history of primary and secondary malignant tumours of the liver. Cancer. 1969;23: 198-202.
2. Fong Y, Kemeny N, Paty P, Blumgart LH, Cohen AM. Treatment of colorectal cancer: hepatic metastasis. Semin Surg Oncol. 1996;12:219-52. (Pubitemid 26255863)
3. Kemeny N, Fata F. Arterial, portal or systemic chemotherapy for patients with hepatic metastasis of colorectal carcinoma. J Hepatobiliary Pancreat Surg. 1999;6:39-49.
4. Steele GJ, Ravikumar TS. Resection of hepatic metastases from colorectal metastases: biologic perspectives. Ann Surg. 1989;210: 127-38. (Pubitemid 19188702)
5. Hurwitz H, Fehrenbacher L, Novotny W, et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer [see comment]. N Engl J Med. 2004;350:2335-42. (Pubitemid 38702844)
6. Saltz LB, Clarke S, Diaz-Rubio E, Scheithauer W, Figer A, Wong R, et al. Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study. J Clin Oncol. 2008;26:2013-9.
7. Tomlinson JS, Jarnagin WR, DeMatteo RP, Fong Y, Kornprat P, Gonen M, et al. Actual 10-year survival after resection of colorectal liver metastases defines cure. J Clin Oncol. 2007;25: 4575-80. (Pubitemid 350035315)
8. Timmerman RD, Bizekis CS, Pass HI, et al. Local surgical, ablative and radiation treatment of metastases. CA Cancer J Clin. 2009;59:145-70.
9. Gruenberger T, Jourdan J-L, Zhao J, King J, Morris DL. Reduction in recurrence risk for involved or inadequate margins with edge cryotherapy after liver resection for colorectal metastases. Arch Surg. 2001;136:1154-7. (Pubitemid 32929343)
10. Seifert JK, Morris DL. Indicators of recurrence following cryotherapy for hepatic metastases from colorectal cancer. Br J Surg. 1998;86:234-40.
11. Seifert JK, Junginger T, Morris DL. A collective review of the world literature on hepatic cryotherapy. J R Coll Surg Edinb. 1998;43:141-54. (Pubitemid 28306028)
12. Seifert JK, Springer A, Baier P, Junginger T. Liver resection or cryotherapy for colorectal liver metastases. A prospective case control study. Int J Colorectal Dis. 2005;20:507-20. (Pubitemid 41479018)
13. Rivoire M, De Cain F, Meeus P, Negrier S, Sebban H, Kaemmerlen P. Combination of neoadjuvant chemotherapy with cryotherapy and surgical resection for the treatment of unresectable liver metastases from colorectal carcinoma. Long term results. Cancer. 2002;95:2283-92. (Pubitemid 35351133)
14. Voyer TEL, Sigurdson ER, Hanlon AL, et al. Colon cancer survival is associated with increasing number of lymph nodes analyzed: a secondary survey of intergroup trial INT-0089. J Clin Oncol. 2003;21:2912-9. (Pubitemid 46621841)
15. Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer. Ann Surg. 1999;230:309-21. (Pubitemid 30191861)
16. Rees M, Tekkis PP, Fenella KS, O'Rourke T, John TG. Evaluation of long-term survival after hepatic resection for metastatic colorectal cancer. A multifactorial model of 929 patients. Ann Surg. 2008;247:125-35.
17. Belluco C, Nitti D, Frantz M, et al. Interleukin-6 blood level is associated with circulating carcinoembryonic antigen and prognosis in patients with colorectal cancer. Ann Surg Oncol. 2000;7:133-8. (Pubitemid 30164682)
18. Benoist S, Brouquet A, Penna C, et al. Complete response of colorectal liver metastases after chemotherapy: does it mean cure? J Clin Oncol. 2006;24:3939-45. (Pubitemid 46630742)
19. Nelson RL, Freels S. Hepatic artery adjuvant chemotherapy for patients having resection or ablation of colorectal cancer metastatic to the liver [review]. Cochrane DB Syst Rev. 2006;4: CD003770.
20. Adam R, Hoti E, Bredt LC. Evolution of neoadjuvant therapy for extended hepatic metastases: have we reached our (nonresectable) limit? J Surg Oncol. 2010;102:922-31.
21. Stang A, Fischbach R, Techmann W, Bokemeyer C, Braumann D. A systematic review on the clinical benefits and role of radiofrequency ablation as treatment of colorectal liver metastases. Eur J Cancer. 2009;45:1748-56.
22. Abdalla EK, Vauthey JN, Ellis LM, et al. Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg. 2004;239:818-27. (Pubitemid 38669432)
23. Pearson AS, Izzo F, Fleming D, et al. Intraoperative radiofrequency ablation or cryoablation for hepatic malignancies. Am J Surg. 1999;178:592-8.
24. Bilchik AJ, Wood TF, Allegra D, et al. Cryosurgical ablation and radiofrequency ablation for unresectable hepatic malignant neoplasms. A proposed algorithm. Arch Surg. 2000;135:657-64. (Pubitemid 30350282)
25. Adam R, Hagopian EJ, Linhares M, et al. A comparison of percutaneous cryosurgery and percutaneous radiofrequency for unresectable hepatic malignancies. Arch Surg. 2002;137:1332-9.